Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease ; volume:16 ; number:1 ; day:10 ; month:10 ; year:2019 ; pages:1-12 ; date:12.2019
Journal of neuroinflammation ; 16, Heft 1 (10.10.2019), 1-12, 12.2019
- Urheber
-
Chatterjee, Pratishtha
Zetterberg, Henrik
Goozee, Kathryn
Lim, Chai K.
Jacobs, Kelly R.
Ashton, Nicholas J.
Hye, Abdul
Pedrini, Steve
Sohrabi, Hamid R.
Shah, Tejal
Asih, Prita R.
Dave, Preeti
Shen, Kaikai
Taddei, Kevin
Lovejoy, David B.
Guillemin, Gilles J.
Blennow, Kaj
Martins, Ralph N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-019-1567-4
- URN
-
urn:nbn:de:101:1-2020022303380709336151
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chatterjee, Pratishtha
- Zetterberg, Henrik
- Goozee, Kathryn
- Lim, Chai K.
- Jacobs, Kelly R.
- Ashton, Nicholas J.
- Hye, Abdul
- Pedrini, Steve
- Sohrabi, Hamid R.
- Shah, Tejal
- Asih, Prita R.
- Dave, Preeti
- Shen, Kaikai
- Taddei, Kevin
- Lovejoy, David B.
- Guillemin, Gilles J.
- Blennow, Kaj
- Martins, Ralph N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease